| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,610,000 |
| Market
Cap: |
83.22(M) |
| Last
Volume: |
1,136,985 |
Avg
Vol: |
1,133,856 |
| 52
Week Range: |
$0.900001 - $2.955 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Media |
| Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
880,962 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-23 |
4 |
S |
$7.50 |
$15,915 |
I/I |
(2,122) |
314,763 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-22 |
4 |
S |
$7.76 |
$1,629 |
I/I |
(210) |
316,885 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-21 |
4 |
S |
$7.90 |
$790 |
I/I |
(100) |
317,095 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-18 |
4 |
S |
$7.92 |
$1,172 |
I/I |
(148) |
317,195 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-17 |
4 |
S |
$7.58 |
$758 |
I/I |
(100) |
317,343 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-16 |
4 |
S |
$7.59 |
$1,518 |
I/I |
(200) |
317,443 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-15 |
4 |
S |
$7.55 |
$3,435 |
I/I |
(455) |
317,643 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2017-08-11 |
4 |
S |
$7.52 |
$45,790 |
I/I |
(6,093) |
318,098 |
|
- |
|
| Thomas Gregory Matthew |
Director |
– • – |
2017-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-07-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
155 |
|
- |
|
| Simtob Richard Isaac |
Director |
– • – |
2017-07-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,099 |
|
- |
|
| Krishnan Ram |
CEO |
• • – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
15,718 |
51,618 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2017-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
7,506 |
35,716 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-12-30 |
4 |
S |
$8.50 |
$19,635 |
I/I |
(2,310) |
324,191 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-12-27 |
4 |
S |
$8.55 |
$3,419 |
I/I |
(400) |
326,501 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-12-23 |
4 |
S |
$8.49 |
$22,094 |
I/I |
(2,602) |
326,901 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-12-22 |
4 |
S |
$9.19 |
$23,425 |
I/I |
(2,550) |
329,503 |
|
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-12-21 |
4 |
S |
$9.50 |
$1,900 |
I/I |
(200) |
332,053 |
|
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2016-11-16 |
4 |
B |
$7.21 |
$28,374 |
I/I |
3,920 |
423,000 |
2.25 |
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2016-11-15 |
4 |
A |
$7.47 |
$3,735 |
I/I |
500 |
2,100 |
|
- |
|
| Wolff Allen |
CFO and EVP |
• – – |
2016-11-15 |
4 |
A |
$7.46 |
$3,730 |
D/D |
500 |
28,210 |
|
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2016-11-15 |
4 |
B |
$7.33 |
$3,665 |
I/I |
500 |
419,080 |
2.17 |
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2016-11-14 |
4 |
B |
$7.20 |
$8,640 |
I/I |
1,200 |
418,580 |
2.17 |
- |
|
| Awm Investment Company, Inc. |
10% Owner |
– – • |
2016-11-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
332,253 |
|
- |
|
| Miller Dave Brian |
SVP Marketing |
• – – |
2016-11-04 |
4 |
A |
$6.64 |
$50,006 |
D/D |
7,531 |
13,131 |
|
- |
|
232 Records found
|
|
Page 8 of 10 |
|
|
0.03 (1.48%) 
